Table 4. CNS Histopathology demonstrates protection from EAE in DA.PVG-Eae23.
DA | DA.PVG-Eae23 | |
Mean (SD) | Mean (SD) | |
Weight at immunization (grams) | 162.9 (9.5) | 153.5 (16.7) |
Adjusted dose (µg MOG/g rat) | 0.092 (0.005) | 0.099 (0.011) |
Incidence (%) | 89 (33) | 69 (48) |
Day of Onset (day p.i.) | 15.6 (9.4) | 22.5 (12.9) |
Max EAE Score | 2.7 (1.2) | 1.5 (1.3)* |
Duration (days) | 20 (8.5) | 10.1 (9.5)* |
Cumulative EAE score | 46.8 (28.4) | 15 (17)* |
Spinal Cord Demyelination | 1.8 (1.6) | 0.09 (0.3)* |
Spinal Cord Inflammation Index | 0.58 (0.46) | 0.14 (0.29)* |
Brain Demyelination | 2.6 (1.8) | 0.35 (1.1)* |
Demyelination in Optic Nerves | 7/9 | 2/13* |
Pons Involvement | 1/9 | 0/13 |
Mann-Whitney U-test was used to compare histopathology phenotypes between parental DA and DA.PVG-Eae23; p values ≤0.05 were considered significant, indicated by *.
Abbreviations: SD = standard deviation, p.i. = post immunization.